• Explore /
  • Poster
  • / Priming immunotherapy with radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC) and head and neck squamous cell cancer (HNSCC): Interim analysis of phase II clinical trial.

Priming immunotherapy with radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC) and head and neck squamous cell cancer (HNSCC): Interim analysis of phase II clinical trial.

Abstract Poster

Authors

Aasems Jacob

Aasems Jacob

University of Kentucky, Lexington, KY

Aasems Jacob , Alexander Kreimer , Jing Wei , Jianrong Wu , Lauren Corum , Ellen Reusch , Jerold Woodward , Donald Cohen , Subbarao Bondada , Val R. Adams , Rachael Morgan , Ronald C. McGarry , William H. St Clair , Mahesh R. Kudrimoti , Zin Myint , Susanne M. Arnold , John L. Villano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Other Checkpoint Inhibitors (Non-PD1/PDL1, Monotherapy, or Combination)

Clinical Trial Registration Number

NCT03313804

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2628)

DOI

10.1200/JCO.2021.39.15_suppl.2628

Abstract #

2628

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Colette Shen

First Author: Carlo Guerrero

First Author: Colette Shen

First Author: Rachel Frascati